F Gavosto

2.3k total citations
112 papers, 1.6k citations indexed

About

F Gavosto is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, F Gavosto has authored 112 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 21 papers in Genetics and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in F Gavosto's work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Acute Lymphoblastic Leukemia research (18 papers). F Gavosto is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Acute Lymphoblastic Leukemia research (18 papers). F Gavosto collaborates with scholars based in Italy, Belarus and Belgium. F Gavosto's co-authors include Alessandro Pileri, Massimo Aglietta, Giovanni Maraini, Luigi Pegoraro, Wanda Piacibello, V. Gabutti, Alessandra Stacchini, Giovanni Camussi, F Sanavio and A Brusca and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Investigation.

In The Last Decade

F Gavosto

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Gavosto Italy 24 829 402 401 365 339 112 1.6k
H Rochant France 26 978 1.2× 604 1.5× 183 0.5× 452 1.2× 336 1.0× 107 1.9k
Miloslav Beran United States 26 1.5k 1.9× 897 2.2× 483 1.2× 757 2.1× 356 1.1× 81 2.5k
Lois W. Dow United States 17 617 0.7× 573 1.4× 238 0.6× 380 1.0× 106 0.3× 32 1.3k
LL Sensenbrenner United States 24 1.2k 1.5× 376 0.9× 500 1.2× 426 1.2× 525 1.5× 67 2.0k
N Williams Australia 25 1.3k 1.5× 509 1.3× 383 1.0× 355 1.0× 734 2.2× 54 2.3k
Manuel E. Kaplan United States 25 786 0.9× 543 1.4× 387 1.0× 944 2.6× 473 1.4× 53 2.3k
Lyle L. Sensenbrenner United States 15 1.1k 1.3× 252 0.6× 444 1.1× 216 0.6× 292 0.9× 28 1.6k
G Isacchi Italy 20 685 0.8× 440 1.1× 241 0.6× 244 0.7× 413 1.2× 75 1.6k
F. Schmalzl Austria 18 424 0.5× 231 0.6× 134 0.3× 247 0.7× 376 1.1× 85 1.1k
T Sato United States 19 840 1.0× 402 1.0× 314 0.8× 284 0.8× 837 2.5× 40 1.8k

Countries citing papers authored by F Gavosto

Since Specialization
Citations

This map shows the geographic impact of F Gavosto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Gavosto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Gavosto more than expected).

Fields of papers citing papers by F Gavosto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Gavosto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Gavosto. The network helps show where F Gavosto may publish in the future.

Co-authorship network of co-authors of F Gavosto

This figure shows the co-authorship network connecting the top 25 collaborators of F Gavosto. A scholar is included among the top collaborators of F Gavosto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Gavosto. F Gavosto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foà, Robert, Giovanna Meloni, S. Tosti, et al.. (2008). Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study. British Journal of Haematology. 77(4). 491–496. 7 indexed citations
2.
Foà, Robin, Giovanna Meloni, Anna Guarini, et al.. (1993). Interleukin-2-Based Immunotherapy in the Management of Minimal Residual Disease in Acute Leukemia Patients. Recent results in cancer research. 131. 207–214. 1 indexed citations
3.
Meloni, Giovanna, Anna Guarini, Marco Vignetti, et al.. (1992). Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.. PubMed. 6 Suppl 3. 115S–116S. 3 indexed citations
4.
Monfardini, S., Umberto Tirelli, Emanuela Vaccher, Roberto Foà, & F Gavosto. (1991). Hodgkir's disease in 63 intravenous drug users infected with human immunodeficiency virus. Annals of Oncology. 2. 201–205. 25 indexed citations
5.
Foà, Roberto, Mt Fierro, Alessandro Guarini, et al.. (1991). Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease. Blood. 78(4). 1041–1046. 4 indexed citations
6.
Foà, Robin, Maria Teresa Fierro, Margherita Bonferroni, et al.. (1990). Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. British Journal of Haematology. 75(1). 34–40. 41 indexed citations
7.
Fierro, Maria Teresa, et al.. (1990). Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2. Leukemia & lymphoma. 1(2). 113–117. 33 indexed citations
8.
Monfardini, S., Emanuela Vaccher, Giorgio Pizzocaro, et al.. (1989). Unusual malignant tumours in 49 patients with HIV infection. AIDS. 3(7). 449–452. 106 indexed citations
9.
Caligaris‐Cappio, Federico, L Bergui, L Tesio, et al.. (1987). Membrane-Microfilament Interactions in the Cells of B-Chronic Lymphocytic Leukemia. Hämatologie und Bluttransfusion. 31. 195–196. 1 indexed citations
10.
Naldini, Luigi, et al.. (1986). Phosphotyrosine Antibodies Identify the p210 c- abl Tyrosine Kinase and Proteins Phosphorylated on Tyrosine in Human Chronic Myelogenous Leukemia Cells. Molecular and Cellular Biology. 6(5). 1803–1811. 49 indexed citations
11.
Aglietta, Massimo, et al.. (1984). Retinoic Acid Enhances the Growth of Only One Subpopulation of Granulomonocyte Precursors. Acta Haematologica. 71(2). 97–99. 10 indexed citations
12.
Aglietta, Massimo, Wanda Piacibello, Alessandra Stacchini, et al.. (1984). Differences in the in vitro growth pattern of fresh and cryopreserved granulo-monopoietic precursors. Cryobiology. 21(5). 486–490. 5 indexed citations
13.
Gavosto, F & Massimo Aglietta. (1981). Normal and leukaemic granulopoiesis.. PubMed. 66(1). 1–17. 4 indexed citations
14.
Matera, Lina, et al.. (1977). The kinetic features of human acute leukaemia as a guide to its chemotherapeutic management.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(4). 343–59. 1 indexed citations
15.
Gavosto, F, et al.. (1969). Different Blast Kinetics in Acute Myeloblastic and Lymphoblastic Leukaemia. Acta Haematologica. 41(4). 215–224. 7 indexed citations
16.
Gabutti, V., et al.. (1967). [Proliferative capacity in acute leukemia after treatment with antiblastics].. PubMed. 43(4). 191–5. 2 indexed citations
17.
Pileri, Alessandro, et al.. (1964). [Correlation between purine metabolism of RNA and protein metabolism in the elements of normal human bone marrow].. PubMed. 40(15). 641–3. 1 indexed citations
18.
Pegoraro, L, Alessandro Pileri, & F Gavosto. (1963). [CHROMOSOME ABNORMALITY IN A CASE OF ACUTE LEUKEMIA WITH MEDULLARY APLASIA].. PubMed. 48. 713–9. 1 indexed citations
19.
Gavosto, F, Giovanni Maraini, & Alessandro Pileri. (1960). Radioautographic Investigations on DNA and Protein Metabolism in 2 Cases of Di Guglielmo’s Disease. Blood. 16(2). 1122–1132. 10 indexed citations
20.
Lenti, G & F Gavosto. (1954). [Practical results of use of triethylenemelamine in neoplastic diseases. III. Lymphosarcoma and reticulosarcoma].. PubMed. 1(1). 103–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Rochant Breakdown of academic impact, for papers by Miloslav Beran Breakdown of academic impact, for papers by Lois W. Dow Breakdown of academic impact, for papers by LL Sensenbrenner Breakdown of academic impact, for papers by N Williams Breakdown of academic impact, for papers by Manuel E. Kaplan Breakdown of academic impact, for papers by Lyle L. Sensenbrenner Breakdown of academic impact, for papers by G Isacchi Breakdown of academic impact, for papers by F. Schmalzl Breakdown of academic impact, for papers by T Sato
Rankless by CCL
2026